Monographs

The ISHLT Monograph Series is an hardcover publication of the Society that provides in-depth coverage of the current state of knowledge of a specific topic relevant to heart and lung transplantation and/or end stage heart and lung disease.

Hardback copies of ISHLT Monographs can be purchased directly from ISHLT, or certain volumes can also be purchased as eBooks from your favorite online retailers.

Published 1 April 2013

Editors:
Order Now

Samuel Goldfarb, MD
Christian Benden, MD
Stuart Sweet, MD
James K. Kirklin, MD

Members - $25.00  |  Non-Members - $60.00

Table of Contents
SECTION 1: Referral Evaluation and Listing

CHAPTER 1: General Referral and Listing Criteria
CHAPTER 2: Disease Specific Issues Regarding Lung Transplantation

  • Part A: Cystic Fibrosis
    Part B: Pulmonary Hypertension
  • Part C: Sufactant Protein Abnormalities/chILD

CHAPTER 3: Timing of Listing and Patient Management on the Waiting List

SECTION II: Peri-transplant Management

CHAPTER 4: Pediatric Aspects of Lung Transplant Surgery - Including Historic Perspective
CHAPTER 5: Pediatric Issues of Donor Selection
CHAPTER 6: Early Post-operative Issues in the Intensive Care Unit

  • Part A: Primary Graft Failure
  • Part B: Pediatric ECMO Support

CHAPTER 7: Immunosuppression Induction & Maintenance Therapy

SECTION III: Post-transplant Complications and Co-morbidities

CHAPTER 8: Infectious Diseases Issues
CHAPTER 9: Monitoring for and Treatment of Acute Allograft Rejection
CHAPTER 10: Diagnosis and Management of Antibody-Mediated Rejection Following Pediatric Lung Transplantation
CHAPTER 11: Monitoring and Treatment of Bronchiolitis Obliterans Syndrome
CHAPTER 12: Gastroesophageal Reflux Disease
CHAPTER 13: Post-transplant Co-morbidities

  • Part A: Chronic Kidney Disease
  • Part B: Diabetes
  • Part C: Bone Health

CHAPTER 14: PTLD and Cancer

SECTION IV: Outcomes

CHAPTER 15: Survival and Functional Status
CHAPTER 16: Special Populations

  • Part A: Living Donor Lung Transplantation
  • Part B: Infant Lung Transplantation
  • Part C: Multi-organ Transplantation
  • Part D: Re-transplantation

CHAPTER 17: Psychosocial Outcomes: Growth and Development
CHAPTER 18: Impact of Developmental Immunology on Outcomes

SECTION V: Psychosocial Aspects

CHAPTER 19: Care Transitions

  • Part A: Transition to Local Care and Scheduled Follow-up
  • Part B: Transition from Pediatric to Adult Services

CHAPTER 20: End of Life Care

  • Part A: Pre-transplant
  • Part B: Post-transplant
SECTION VI: The Future

CHAPTER 21: Future of Pediatric Lung Transplantation